Tag: antibody

engineered algae

Green Algae

Green algae.

Scientists are trying to figure out a way to reduce costs of producing targeted cancer treatments. Popular Science highlights a research group who engineered algae to produce and antibody conjugated with a fragment of the toxic protein, exotoxin A, from P. aeruginosa.

But recently, a group of scientists at University of California, San Diego engineered algae to produce a human antibody with a built-in toxic weapon–a ready-made molecular cancer assassin. The researchers produced the new therapy by embedding the genetic code of the toxin P. aeruginosa into a human antibody gene, which they then spliced into the algae’s DNA.

In their research paper, the scientists note that this feat has been attempted before, using bacteria instead of algae, but the bacteria weren’t capable of folding the complex antibody into the right shape, so the method required a researcher to follow along behind and refold the proteins. The new therapy could not be produced by mammal cells, either, the researchers write, because the presence of the toxin would prohibit the engineered cells from reproducing.

If the new treatment is able to stand up to the battery of medical trials required by law, the targeted, assassin-style fight against cancer may soon get a lot more affordable.

More here and here.

hiv antibodies

Schematic diagram of an HIV virus and it’s coat glycoprotein bound to an antibody. Image from Corpus Christi College Oxford.

A South African study offers hope that an HIV vaccine can be developed. Certain changes in the virus’ coat proteins appear to trigger a more robust production of antibodies. From NPR news:

One of the women had neutralized 88 percent of 225 HIV virus subtypes after three years with the virus, while the other woman had neutralized 46 percent of 41 subtypes after two years of infection.

The researchers found that a specific change in the coating of the HIV virus appeared to be the trigger for the women to produce antibodies that could thwart its entry into cells.

One reason the HIV virus has proven so difficult to fight is that it is skilled at hiding from antibodies that can block the virus from attacking cells. But researchers believe that the more they understand how the antibodies develop, the better chance they have at developing an HIV vaccine.
 

The original research paper appears in Nature magazine.

//eensaulsigu.net/4/4535925